These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38351012)

  • 1. BeHERE's effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings.
    Kenefick HW; Wing A
    Harm Reduct J; 2024 Feb; 21(1):38. PubMed ID: 38351012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England.
    Fulop NJ; Walton H; Crellin N; Georghiou T; Herlitz L; Litchfield I; Massou E; Sherlaw-Johnson C; Sidhu M; Tomini SM; Vindrola-Padros C; Ellins J; Morris S; Ng PL
    Health Soc Care Deliv Res; 2023 Jul; 11(13):1-151. PubMed ID: 37800997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "The new normal has become a nonstop crisis": a qualitative study of burnout among Philadelphia's harm reduction and substance use disorder treatment workers during the COVID-19 pandemic.
    Unachukwu IC; Abrams MP; Dolan A; Oyekemi K; Meisel ZF; South EC; Aronowitz SV
    Harm Reduct J; 2023 Mar; 20(1):32. PubMed ID: 36906576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
    Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
    Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond.
    Bergman BG; Kelly JF
    J Subst Abuse Treat; 2021 Jan; 120():108152. PubMed ID: 33129636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
    Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
    Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
    Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.
    Glick JL; Zhang L; Rosen JG; Yaroshevich K; Atiba B; Pelaez D; Park JN
    JMIR Form Res; 2023 Apr; 7():e42418. PubMed ID: 37052977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the sector-wide implementation of virtual child and youth mental health services in response to the COVID-19 pandemic: Perspectives from service providers, agency leaders and clients.
    Danseco E; Kurzawa J; Sundar P; Brown J; Huang C
    Implement Res Pract; 2021; 2():26334895211045690. PubMed ID: 37089999
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.